Clinical Trials

Showing trials with last updates posted in 2024.

NCT06539208 | RECRUITING | PHASE1/PHASE2
31 participants

A Phase I/IIa,Open-label, Single Ascending Dose and Dose-expansion Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of YOLT-201 in Patients With Transthyretin Amyloidosis Polyneuropathy (ATTR-PN) or Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM)

Study Type:
INTERVENTIONAL
Last Updated:
2024-08-06
Start Date:
2024-05-23
Completion:
2025-06-30
Conditions
  • Transthyretin Amyloidosis Polyneuropathy
  • Transthyrexin Amyloidosis Cardiomyopathy
Interventions
  • DRUG
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page